{"id":48348,"date":"2024-06-07T09:22:15","date_gmt":"2024-06-07T08:22:15","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=48348"},"modified":"2024-06-07T09:22:15","modified_gmt":"2024-06-07T08:22:15","slug":"researchers-develop-ai-blood-test-to-diagnose-lung-cancer","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/researchers-develop-ai-blood-test-to-diagnose-lung-cancer\/48348\/","title":{"rendered":"John Hopkins Medicine researchers develop AI blood test to diagnose lung cancer"},"content":{"rendered":"
The team has performed a prospective study to demonstrate that AI technology<\/a> could effectively identify people who are more likely to have lung cancer based on DNA fragment patterns in blood.<\/p>\n This new blood test could improve screening and reduce death rates by identifying high-risk patients who would benefit from follow-up CT scans, according to the team’s computer modelling.<\/p>\n The study’s corresponding author,\u00a0Victor Velculescu, MD, PhD, explained: “We have a simple blood test that could be done in a doctor’s office that would tell patients whether they have potential signs of lung cancer and should get a follow-up CT scan.”<\/p>\nLimitations of current lung cancer diagnostics<\/h3>\n